The use of functional quantitative biomarkers extracted from routine PET–CT scans to
characterize clinical responses in patients with lymphoma is gaining increased attention …

Primary mediastinal large B cell lymphoma (PMBCL) is an aggressive large B cell
lymphoma originating in the mediastinum, that mainly expresses B cell surface molecules …

Cure rates for primary mediastinal large B-cell lymphoma (PMBCL) have improved with the
integration of rituximab. However, the type of primary therapy and role of radiotherapy (RT) …

About 70% of patients with large B-cell lymphoma (LBCL) who are treated with
axicabtagene ciloleucel (axi-cel) and who achieve a partial response (PR) or stable disease …

The impact of pre-treatment maximum standardized uptake value (SUV max) on the
outcome of follicular lymphoma (FL) following specific frontline regimens has not been …

Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct clinicopathologic disease
from other types of diffuse large B-cell lymphoma (DLBCL) with unique prognostic features …

Purpose Treatment strategies of lymphoid malignancies have been revolutionized by
immunotherapy. Because of the inherent property of Hodgkin lymphoma and some subtypes …

Lymphomas are the most common hematological malignancies and are further
distinguished in Hodgkin lymphoma (HL) and non-Hodgkin (NHL). For staging purposes …

Purpose To evaluate the prognostic role of end-of-treatment (EoT) FDG-PET/CT parameters
in diffuse large B cell lymphoma (DLBCL), and then to explore a pilot application of Neural …

Among the different metrics that are used to describe tumor burden and tumor metabolic
activity, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) have become …